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FIBER INTAKE IN HEMODIALYSIS PATIENTS AND ITS EFFECTS ON SYMPTOMS 
 
 
JENNIFER LANGNER 
40 Pages 
On average 30 million adults are diagnosed with chronic kidney disease (CKD) in the 
United States (National Kidney Foundation, 2017). Patients in late stage kidney disease and on 
dialysis are placed on a restrictive diet to aid in the treatment of their disease. There are adverse 
symptoms associated with dialysis including nausea, constipation, diarrhea and fatigue. Fiber has 
been shown to decrease gastrointestinal symptoms such as reducing constipation and 
inflammation in the body in healthy populations. This study examined 19 hemodialysis dialysis 
patients and their fiber intake in relation to a variety of symptoms such as constipation, nausea, 
vomiting, diarrhea, appetite and dry mouth. Results determined that there is a positive correlation 
between soluble fiber and diarrhea severity (p=0.047). There were other variables that were 
approaching significance such as dietary fiber and diarrhea frequency and severity and soluble 
fiber and diarrhea frequency. In conclusion there was a connection between fiber and diarrhea 
severity, however, more research is required to conclude that nutrition interventions with fiber 
would be beneficial for this demographic.  
KEYWORDS: hemodialysis; fiber intake; symptoms; gut microbiota; symptom severity; 
symptom frequency 
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CHAPTER I: DIALYSIS AND FIBER INTAKE  
 
Introduction 
Approximately 30 million adults in the United States are diagnosed with chronic kidney 
disease (CKD) (National Kidney Foundation, 2017). The kidney is a bean shaped organ located 
in the superior lumbar region (Marieb, 2013). Functional kidneys have a crucial role in 
maintaining electrolyte and fluid balance along with helping filter metabolic waste products and 
removing additional fluid from the blood to be excreted as urine (Mahan, 2012).  The kidney also 
has additional roles unrelated to excretion of urine including blood pressure control, hormone 
production and maintenance of calcium/phosphorus homeostasis (Mahan, 2012).  
Some conditions that can lead to declining kidney function include inflammation, 
repeated urinary infections, lupus, with the most common etiologies of diabetes and high blood 
pressure (Chronic kidney disease, 2018). Kidney function is measured with glomerular filtration 
rate (GFR). GFR is also used to categorize the severity of the disease (Mahan, 2012).  This test 
quantifies the amount of blood being filtered and the amount of creatine being cleared. (Chronic 
kidney disease, 2018; Mahan, 2012). A normal GFR rate is 90 or greater and those in kidney 
failure typically have a GFR of 15 or less (National Kidney Foundation, 2017).  If kidney 
function continues to decline a patient might require dialysis to replace functions normally 
conducted by healthy kidneys. This intervention is necessary in end stage renal disease (ESRD).  
One of the forms of dialysis is hemodialysis where the patient is connected to a machine 
to serve as an artificial kidney to help filter the blood. During hemodialysis, the patient’s blood 
gets filtered through a dialyzer which helps remove additional fluid, remove waste products, and 
return the filtered blood to the patient (Hemodialysis, 2018). The treatment lasts about 3-5 hours 
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and the patient comes into a clinic roughly three times per week (Mahan, 2012). This process 
along with following a renal diet can help maintain the health of the patients experiencing kidney 
failure.  
Patients on hemodialysis are typically on a restrictive diet of high protein, low potassium 
and sodium, and management of fluid intake (K/DOQI, 2005). Patients on dialysis are advised to 
have higher protein consumption to attenuate the catabolic state of the treatment and to preserve 
lean body mass, which can also lead to a decreased rate of hospitalization (Chao, 2017). High 
circulating potassium can cause cardiac arrhythmias and a reduction of blood pressure leading to 
a higher risk of cardiovascular complications (Ko, 2017). The food items with the most 
potassium include fruits, vegetables, whole grains and legumes (National Kidney Foundation, 
2017). Phosphorus is also recommended to be limited because of its connections with 
cardiovascular disease along with all cause mortality in patients with CKD (Hou, 2017; Suki, 
2016). Phosphorus works alongside potassium to maintain fluid balance and bone formation and 
is found in foods such as beans, legumes, dairy products and whole grains (Thompson, 2014). 
With the reduction of food items and the symptoms of kidney disease, it can be challenging to 
find foods the patients can eat. Because of the aggressive treatment during dialysis, it can lead to 
a variety of symptoms that can hinder the quality of life of these patients.  
There are associated symptoms that a patient can experience before, during, and after 
treatment. Some of the symptoms include weakness or lack of energy, decreased mobility, 
shortness of breath, and nausea and vomiting (Raj, 2017). Previous research has looked at 
patients on hemodialysis and the association between nutritional status and quality of life. There 
have been additional studies looking at nutrition interventions and the maintenance of these 
symptoms and quality of life, however; fiber is not well studied.  
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As mentioned previously, hemodialysis patients are counseled to reduce high potassium 
and high phosphorus foods such as fruits, vegetables, whole grains, beans and legumes. All of 
these food items are excellent sources of fiber and have numerous health benefits. Fiber has been 
shown to help with lowering the risk of heart disease, gastrointestinal diseases and cholesterol 
levels (Anderson, 2009). Currently, heart disease is the leading causes of mortality in CKD 
patients (United States renal data system, 2018). Dietary fiber also helps with constipation by 
increasing fecal bulk in the large intestine and increasing the amount of water to help soften the 
stool (Lambeau, 2017). Finally, it can help with supporting diverse bacteria populations 
comprising the gut microbiota (Chung, 2016; Simpson, 2015). There are little data assessing the 
connection between fiber intake and symptom severity in patients on hemodialysis. 
The purpose of this study was to discover the connection between dialysis patients’ 
reported fiber intake and reported symptoms. The dietary intake specifically addressing the total 
amount of fiber was compared to the symptoms the patient experiences. It was hypothesized that 
the increase in fiber will lead to a decrease in symptom severity because of the overall health 
benefits associated with fiber intake.   
 
Methods and Results 
A purposive sample of 20 participants in this cross-sectional study were recruited from 
the Fresenius Kidney Clinic in Central Illinois. Inclusion criteria included English speaking, aged 
18 and above, receiving hemodialysis and experiencing two or more kidney disease related 
symptoms. Exclusion criteria included receiving peritoneal dialysis, had a kidney transplantation, 
had a diagnosed gastrointestinal illness such as inflammatory bowel disease or had received 
antibiotics or probiotics in the past three months.  
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Data was collected by interviewing patients and obtain a demographics, health condition 
form, and informed consent. The demographics form collected data on gender, income, ethnicity, 
education, and marital status. The heath condition form gathered information on behaviors, 
dialysis-related gastrointestinal health and symptoms experiencing in the last week.  Participants 
also completed a food frequency questionnaire (FFQ) and dialysis frequency, severity, and 
symptom burden index (DFSSBI) on their own or with assistance from the researchers.  
All procedures were approved by the Institutional Review Board (IRB) prior to 
recruitment or data collection.  An incentive of a $20 gift card to Wal-Mart was given to thank 
participants for their time. These gift cards were distributed after all documentation was 
completed and turned in to the researcher.  
Instrumentation 
The Block Dialysis FFQ was utilized to analyze the overall diet with specific emphasis 
on fiber intake. This questionnaire was utilized because of its validation in the hemodialysis 
population (Kalantar-Zadeh, 2011). The FFQ quantifies specifically the amount of dietary fiber, 
dietary soluble fiber and fiber from food sources such as beans, vegetables, fruits and grains. The 
amount of fiber in the diet was recorded per respondent along with sex, age, weight and body 
mass index (BMI). Dialysis frequency, severity, and symptom burden index (DFSSBI) analyzes 
a 31-item index to observe severity of symptoms or distress in the last dialysis treatment, 
specifically looking at appetite and fatigue. Kidney disease quality of life (KDQOL) evaluates 36 
items in terms of health quality and dialysis specific testimonials (Peipert, 2018). 
Data Analysis  
Statistical analysis was performed using IBM Statistical Package for the Social Sciences 
(SPSS) version 24. Means along with standard deviations were reported in the descriptive data. 
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A pearson correlation coefficient test determined the relationship between fiber intake and the 
symptom severity of the patient. Relationships between fiber intake and reported patient quality 
of life were also analyzed. A statistically significant p value was set at p<0.05.  
Results 
This study investigated the connection between fiber and symptoms of constipation, 
nausea, vomiting, diarrhea, appetite and dry mouth associated with hemodialysis treatment. 
Participants completed a series of surveys including a food frequency questionnaire (FFQ) and 
dialysis frequency, severity, and symptom burden index (DFSSBI). Table 1 describes the 
demographic of the participants. There were a total of 20 participants (n=20) who participated in 
the study and one participant dropped out prior to the study ending. There were on average more 
females than males (females 78.9% (n=15); males 21.1% (n=4)) with ages between 29-91 years 
old. Weight was measured in kg and on average participants weighed 87.95 kg (SD=23.10). 
Body mass index was calculated to be on average 29.16 (SD= 7.71), which falls in the 
overweight category. After participants completed the FFQ, data analysis was conducted to 
determine the total amount of dietary fiber and soluble fiber per day. On average, participants 
consumed 12.55 grams of dietary fiber and 4.36 grams of soluble fiber (Table 2).  
While looking at the symptoms, variables were broken down into symptom frequency, 
symptom severity and symptom bother. Dietary fiber and soluble fiber were compared to the 
symptoms of constipation, nausea, vomiting, diarrhea, appetite and dry mouth. A Pearson 
correlation coefficient (p<0.05) determined the correlation between the type of fiber and the 
symptom variables. There was a statistically significant positive correlation between soluble 
fiber and diarrhea severity with a Pearson correlation value of 0.460 (p=0.047) (Table 3).   
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There were multiple variables that were approaching significance but were not 
statistically significant. Table 4 outlines the relationship between dietary fiber and symptom 
frequency. There is a positive relationship between dietary fiber and diarrhea frequency with a 
Pearson correlation of 0.416 (p=0.077). Soluble fiber and diarrhea frequency have a correlation 
of 0.430 (p=0.066) (Table 6). Table 5 shows the correlation between dietary fiber and symptom 
severity. The relationship between dietary fiber and diarrhea severity was approaching 
significance with a Pearson correlation of 0.427 (p=0.068). Finally, there was no statistically 
significant relationship between dietary fiber and symptom bother (Table 7) and soluble fiber 
and symptom bother (Table 8).  
 
Discussion 
The DFSSBI was a detailed survey asking patients about their hemodialysis-related 
symptoms and specifically for this study the focus was in frequency, severity and bother of six 
symptoms. The main statistically significant connection between fiber and symptoms was 
determined between soluble fiber and diarrhea severity. This study concluded that an increase in 
soluble fiber was associated with an increase in diarrhea severity. There were additional trends 
identified between dietary fiber and diarrhea frequency, severity and soluble fiber and diarrhea 
frequency. Even though these results were not statistically significant, other research has 
concluded that fiber intake relates to diarrhea. These results can be rationalized by the impaired 
kidney function, impaired colon function and medications that a patient with CKD is prescribed.  
When evaluating total amount of dietary and soluble fiber in CKD patients’ diet, the 
average amount of fiber consumed by dialysis patients is 15.4 g/day (Chiavaroli , 2015). Patients 
who participated in this study consumed just under this average, 12.55 g/day of dietary fiber. 
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Some of the common sources of fiber for the participants included pizza, high protein renal 
drinks, vegetables, fruits and cereal. Fiber has multiple roles, which could potentially aid in 
treatment options for patients on dialysis. One of the roles of dietary fiber is to reduce colon-
derived solutes and lower plasma urea by reducing the amount of ammonia (Sirich, 2015). There 
is a conversion of diffusible ammonia to ammonium, which will lead to nitrogen being excreted 
by the feces (Chiavaroli, 2015). This should in turn create less diarrhea, however, the findings 
from this study do not support this outcome.  
The kidneys help filter the blood and prevent accumulation of waste products in the blood 
(Poesen, 2013). Because of the impairment to the kidneys to filter the blood and eliminate toxins 
in CKD, there is a high risk of microbial dysbiosis (Khodor, 2017). Medications, acidosis and 
altered colonic transit time are associated with microbial dysbiosis, which can trigger an 
inflammatory response and an increase in toxins such as urea (Khodor, 2017). Along with urea 
being produced, ammonia is also produced and aids in bacterial growth in the colon (Sato, 2005). 
A previous study looked at fecal ammonia and urea and its relation to diarrhea in cows. Cows 
that had an increase in ammonia had an increase in diarrhea symptoms (Sato, 2005). While cows 
do have a different digestive system, this can be applied to the finding from this study in that 
dialysis patients typically have increased urea leading to increased ammonia levels, which may 
have been contributory to the participants’ diarrhea (Gauchan, 2015; Gowda, 2010). 
The colon’s responsibility in the body is to absorb water and salt and absorb other 
nutrients produced from bacterial fermentation of dietary fiber (Khodor, 2017). If the colon is not 
functioning properly it could lead to an increase in water in the feces leading to diarrhea. 
Previous studies have looked at rats with chronic renal failure and the amount of water in the 
feces in relation to the colonic transit time. Because of a reduced colonic transit time the rats 
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experienced a higher amount of water in the feces in relation to chronic renal failure (Fu, 2011). 
This same study also made a connection with the length of the colonic transit time. A reduced 
transit time led to an increase in diarrhea and an increased transit time led to an increase in 
constipation (Fu, 2011). The duration per treatment of the dialysis could also affect the severity 
of diarrhea. There is a higher probability of patients who are on longer term dialysis to 
experience more diarrhea during their treatment (Fu, 2011). Increased water in feces and 
decreased transit times due to dialysis could have been another reason for these participants’ 
diarrhea. This study did not specifically address a duration per treatment of dialysis nor the total 
length of time the participant was receiving dialysis. Colonic transit time could have been 
reviewed in these participants to determine if this was a causative factor to their diarrhea.   
In addition to physiological changes in the body with CKD, patients on dialysis take a 
variety of medications to aid in treatment and decrease symptom bother. Anemia management is 
one situation that can arise in dialysis patients which leads to patients being prescribed methoxy 
polyethylene glycol (commercial name: Mircera) (Frimat, 2013). According to the U.S Food and 
Drug Administration (FDA) one of the common symptoms for dialysis patients is diarrhea, 
which can occur in greater than 10% of patients (FDA, 2015). This may have been another 
contributing factor to why these participants exhibited diarrhea. Erythropoietin is another 
medication that aids in anemia correction (Provatopoulou, 2011).  Erythropoietin has been seen 
to have influenza like symptoms with long-term administration (Singbarti, 1994). These two 
medications are a few that patients in this study were administered. There could be a 
bidirectional relationship with the medications patients are prescribed and the symptoms 
associated during their treatment.  
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This study is one of the few studies to look at fiber intake in relation to symptoms 
experienced on while dialysis. One additional study in particular looked at the connection 
between soluble fiber and diarrhea symptoms. That study concluded that soluble fiber leads to an 
increase in fecal weight but also leads to an increase in stool water content. This study concluded 
that there is no statistically significant evidence to confirm that fiber was effective at treating 
diarrhea (Slavin, 2009). Most of the literature revolves around protein energy wasting, urea and 
creatine concentrations and other diseases that contribute to renal disease such as cardiovascular 
disease. This study did address protein and urea concentrations slightly but did not address other 
metabolic factors. An area that could be expanded on is fiber intake and its relation to decreasing 
cardiovascular disease symptoms in patients with CKD.  
This study was performed in one dialysis clinic and had numerous inclusion and 
exclusion criteria, however, there are areas that could be improved to increase the accuracy of 
the study. There are different factors in this study that can be addressed to explain the evidence 
presented and why they conflict with previous research. Some potential errors of the study could 
be small sample size, effectiveness of the food frequency questionnaire, and timing of dialysis. 
There was one participant who chose to withdraw from the study resulting in a total of 19 
participants. Future researchers should increase the sample size to get a larger range of 
participants entering into the study to make the results more generalizable. In this study there 
was a range of length of dialysis. Some patients started dialysis three weeks prior and others 
have been on dialysis for multiple years. To have a more controlled investigation, there should 
be a length of time that a participant should be on dialysis to be included in the inclusion criteria. 
More data should have been analyzed in relation to blood chemistry. Accurate reporting of urea 
and ammonia levels could have supported the conflicting results from previous research 
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regarding increased fiber intake and diarrhea. These participants also had polypharmacy, which 
could have skewed results relating to diarrhea. Finally, quality of the fiber sources were not 
evaluated in this study. As mentioned previously, some of the common sources of fiber included 
pizza, protein shakes and cereal. There could have been a discussion on if the patient is currently 
speaking and meeting with a dietitian and if they are following the renal diet with healthy forms 
of fiber. 
 
Conclusion 
CKD is a chronic progressive disease that requires a large amount of research to 
understand the progression of the disease. Nutrition interventions and maintenance of nutrition 
status can potentially aid in the progression and potentially decrease the mortality of the patients. 
This study was conducted to determine a connection between fiber intake and symptom severity, 
bother and frequency in dialysis patients. After performing the FFQ and from evidence 
concluded in the Pearson correlation coefficient analysis, there is a connection between soluble 
fiber and diarrhea symptoms. There are multiple variables that were approaching significance, 
which all related to fiber and diarrhea. Overall, more research is required to determine if fiber 
can directly relate to a positive benefit on dialysis patients and a variety of symptoms. 
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Table 1 
Demographics (mean, median, mode, SD) (n=19) 
 Mean  Standard 
Deviation 
(SD) 
Gender Male: 
21.1% 
Female: 
78.9% 
 
Weight  87.95 
kg 
23.10 
BMI 29.16 7.71 
 
 
Table 2 
Mean and standard deviation of dietary fiber and 
soluble fiber intake 
 Mean  SD 
Dietary 
Fiber  
12.55 
grams 
6.92 
Soluble 
Fiber 
4.36 
grams 
2.24 
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Table 3 
Soluble fiber correlation with symptom severity (n=19) 
*Correlation is significant at the 0.05 level (2-tailed) 
*Symptom severity was measured using a 1-10 scale with 1 being the least severe and 10 being the most severe 
 
 
 
 
Table 4 
Dietary fiber correlation with symptom frequency (n=19) 
 Pearson 
Correlation 
Sig. (2-tailed) Mean SD 
Constipation 
Frequency 
-0.096 0.695 2.474 3.549 
Nausea 
Frequency 
-0.218 0.371 1.790 3.207 
Vomiting 
Frequency 
-0.196 0.422 1.895 3.348 
Diarrhea 
Frequency 
0.416 0.077 1.632 2.650 
Appetite 
Frequency 
-0.057 0.817 2.316 3.334 
Dry mouth 
Frequency 
0.191 0.432 3.632 3.864 
*Correlation is significant at the 0.05 level (2-tailed) 
*Symptom frequency was measured using a 1-10 scale with 1 being the least frequent and 10 being the most 
frequent 
 
 
 
 
 
 
 Pearson 
Correlation 
Sig. (2-tailed) Mean SD 
Constipation 
Severity 
-0.020 0.440 2.737 3.709 
Nausea Severity -0.132 0.589 1.579 2.893 
Vomiting 
Severity 
-0.117 0.663 1.895 3.089 
Diarrhea 
Severity 
0.460* 0.047 1.9474 3.223 
Appetite 
Severity 
-0.131 0.593 2.053 2.990 
Dry mouth 
severity 
0.128 0.602 2.947 2.972 
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Table 5 
Dietary fiber correlation with symptom severity (n=19) 
 Pearson 
Correlation 
Sig. (2-tailed) Mean SD 
Constipation 
Severity 
-0.110 0.653 2.737 3.709 
Nausea Severity -0.184 0.450 1.579 2.893 
Vomiting 
Severity 
-0.171 0.483 1.895 3.089 
Diarrhea 
Severity 
0.427 0.068 1.9474 3.223 
Appetite 
Severity 
-0.160 0.514 2.053 2.990 
Dry mouth 
Severity 
0.114 0.642 2.947 2.972 
*Correlation is significant at the 0.05 level (2-tailed) 
*Symptom severity was measured using a 1-10 scale with 1 being the least severe and 10 being the most severe 
 
 
 
Table 6 
Soluble fiber correlation with symptom frequency (n=19) 
 Pearson 
Correlation 
Sig. (2-tailed) Mean SD 
Constipation 
Frequency 
0.014 0.956 2.474 3.549 
Nausea 
Frequency 
-0.179 0.464 1.790 3.207 
Vomiting 
Frequency 
-0.154 0.528 1.895 3.348 
Diarrhea 
Frequency 
0.430 0.066 1.632 2.650 
Appetite 
Frequency 
-0.024 0.923 2.316 3.334 
Dry mouth 
Frequency 
0.168 0.491 3.632 3.864 
*Correlation is significant at the 0.05 level (2-tailed) 
*Symptom frequency was measured using a 1-10 scale with 1 being the least frequent and 10 being the most 
frequent 
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Table 7 
Dietary fiber correlation with symptom bother (n=19) 
 Pearson 
Correlation 
Sig. (2-tailed) Mean SD 
Constipation 
Bother 
-0.064 0.795 0.842 1.425 
Nausea Bother -0.092 0.709 0.684 1.204 
Vomiting 
Bother 
-0.340 0.154 0.632 1.383 
Diarrhea 
Bother 
0.282 0.243 0.632 1.257 
Appetite Bother -0.314 0.191 0.737 1.240 
Dry mouth 
Bother 
-0.074 0.765 1.158 1.463 
*Correlation is significant at the 0.05 level (2-tailed) 
*Symptom bother was measured using a 0-4 scale with 0 being not very much and 4 being very much 
 
 
 
 
 
Table 8 
Soluble fiber correlation with symptom bother (n=19) 
 Pearson 
Correlation 
Sig. (2-tailed) Mean SD 
Constipation 
Bother 
0.025 0.920 0.842 1.425 
Nausea Bother -0.045 0.855 0.684 1.204 
Vomiting 
Bother 
-0.303 0.207 0.632 1.383 
Diarrhea 
Bother 
0.283 0.240 0.632 1.257 
Appetite Bother -0.306 0.203 0.737 1.240 
Dry mouth 
Bother 
-0.073 0.765 1.158 1.463 
*Correlation is significant at the 0.05 level (2-tailed) 
*Symptom bother was measured using a 0-4 scale with 0 being not very much and 4 being very much 
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CHAPTER II: REVIEW OF THE LITERATURE  
 
End stage renal disease (ESRD) is a chronic condition that is evaluated medically and 
nutritionally. Nutrition assessments have been completed and research has been conducted on 
patients in ESRD. There are different ways to measure the nutrition status of patients, and many 
of these tests revolve around macronutrients and micronutrients on a larger scale. By having a 
better understanding of this, it will allow a study to review certain nutrients and its effect the 
symptoms experienced with dialysis and ESRD. With a better understand on how different 
macronutrients and micronutrients interact in the body, researchers can better understand 
different treatment methodologies to enhance the quality of care of dialysis patients.  
 
Chronic Kidney Disease (CKD) 
 Chronic kidney disease (CKD) is characterized as the inability of the kidneys to perform 
proper function due to damage (Escott-Stump, 2015). Due to improper kidney function, there is 
an excess build up of urea and other nitrogenous waste products that cannot be circulated out of 
the bloodstream, (Escott- Stump, 2015). Some of the common risk factors associated with CKD 
include diabetes, family history, smoking, hypertension and obesity (Kazancioğlu, 2013). There 
are some modifiable risk factors with CKD including obesity, hyperglycemia and anemia 
(Escott-Stump, 2015). There are five different stages of CKD, and each stage is categorized by a 
decrease in glomerular filtration rate (GFR) (Mahan, 2012). GFR is used to determine how the 
kidneys are functioning and is considered the gold standard of testing for kidney function (Jin, 
2008). Once a patient surpasses stage four, severe decrease of function, and is in stage five, 
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kidney failure, medical treatment for end stage renal disease (ESRD) is required for management 
of symptoms (Mahan, 2012).  
Some common symptoms of ESRD are nausea, vomiting, metallic taste in the mouth and 
cramps (Mahan, 2012). Findings as to why symptoms arise from CKD include edema, anemia, 
weight loss and hyperkalemia (Chaudhry, 2018). Aside from physical symptoms, psychological 
symptoms can also arise such as anxiety, depression and irregular sleep (Chong, 2013). 
Depression is one of the most common psychiatric symptoms related to dialysis, and this can 
lead to lower adherence of treatment, higher mortality and higher risk of peritonitis (AlDukhayel, 
2015).  
CKD is not a disease that stands alone, rather, there are other disease that can occur for 
these patients. The common disease includes cardiovascular disease, diabetes and hypertension. 
These diseases can either be a contributor as to when a patient has CKD or it can be a result of 
the diagnosis of CKD. CKD is a risk factor for cardiovascular disease and hypertension. 
Mortality risk is 10-30 times higher in individuals with CKD than the healthy population 
(Sarnak, 2003). Diabetes also can cause kidney failure because of insulin resistance properties of 
CKD.  
 
Peritoneal Dialysis and Hemodialysis 
Dialysis is a process where the blood is cleaned to remove solutes and waste products, 
which is usually accomplished by a functioning kidney (Escott-Stump, 2015). There are two 
common treatment options: Peritoneal dialysis and hemodialysis. To determine which treatment 
option is the most appropriate, a physician needs to understand the motivation of the patient, 
education, financial situation and other external factors (Sinnakirouchenan, 2011). Families of 
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the patient have to discuss which method will best suit the patient’s needs in terms of time, 
available assistance if performing the dialysis at home and water supply in the home (Mahan, 
2012). 
Peritoneal dialysis utilizes the peritoneum, or membrane surrounding abdominal organs, 
and utilizes a solution called dialysate via a catheter to excrete waste byproducts from the body 
(Mahan 2012; Peritoneal dialysis, 2018). There are two options if peritoneal dialysis is needed: 
continuous ambulatory peritoneal dialysis or intermittent peritoneal dialysis (Escott-Stump, 
2015). There are advantages of peritoneal dialysis including a decrease in variability of blood 
chemistry levels, less invasive, ability to live a more normal life and cost effective (Mahan 2012; 
Pratsinis, 2018).  
In hemodialysis, the waste products in the blood are diffused and removed from the blood 
by an artificial kidney (Mahan, 2012). A typical treatment of hemodialysis takes three to five 
hours and treatment is done three days a week (Mahan, 2012). Some considerations to take with 
hemodialysis are availability to show up at a clinic, the health status of the patient, transportation 
and family support (Alazmi, 2018). Protein wasting is also a concern with hemodialysis. About 
40% of patients on hemodialysis have different stages of protein wasting so nutrition status must 
be assessed regularly (Escott-Stump, 2015). 
 
Nutrition Intervention 
 Nutrition counseling and intervention can help with the treatment of numerous diseases. 
Some common data collected include anthropometrics, biochemical and general communication 
about nutrition habits (Martin, 2009). When a patient is diagnosed with chronic kidney disease 
(CKD), they are put on a restrictive diet to help with their compromised renal system. These 
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restrictions are due to the treatment plan they are put on and there is still controversy on the 
amount of food that they should eat before treatment. There are a variety of restrictions that these 
patients have, which makes the patients wonder what they can eat. Some of the nutrients that 
need to be monitored are protein, phosphorus, potassium, fluid and some vitamins and minerals 
(Kalantar-Zadeh, 2015). 
For patients categorized as “pre-dialysis,” they are advised to eat a lower amount of 
protein to help with the compromised kidney (Kalantar-Zadeh, 2015). Some other rationales are 
to help reduce nitrogen intake, increase caloric consumption and reduce stress on the 
gastrointestinal tract (Locatelli, 2017). When a patient transitions to dialysis, they are in a high 
catabolic state so the risk of protein energy wasting (PEW) is high (Radjen, 2018). Some causes 
of PEW can include the patient not being able to make their own food, depression, a 
hypermetabolic disorder or dietary restrictions based off dietitian recommendation (Radjen, 
2018). Some research recommends that a patient on dialysis should have a protein intake of 1.2-
1.4 g/kg/day, which is two times higher than those on non-dialysis (Kalantar-Zadeh, 2015). One 
of the risks of increasing protein can be a higher amount of phosphorus and potassium, which 
can increase the acidic environment of the body (Kalantar-Zadeh, 2015).  
If patients on dialysis consume too much phosphorus, it can lead to weakened bones, 
disruption in heart and muscle function and joint problems (National Kidney Foundation, 2017). 
When there is too much phosphorus in the body, calcium is pulled from the bones leading to a 
risk of brittle bones and breaks (National Kidney Foundation, 2017). For dialysis patients, it is 
recommended for there to be a reduction of phosphorus because the kidneys have a decreased 
ability to remove phosphorus, which can also lead to an increase of removal of calcium from the 
bones (National Kidney Foundation, 2017). Phosphorus is found in a variety of protein based 
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foods, and if there is a reduction in the amount of phosphorus they are eating, professionals need 
to monitor the patient to ensure these patients are not limiting protein intake to avoid muscle 
wasting (Kalantar-Zadeh, 2015). It is recommended for patients to stay at an average of less than 
800 mg/day (Kalantar-Zadeh, 2015).  
Potassium is also a nutrient that is restricted for hemodialysis patients because of the risk 
of an increased mortality risk (Kalantar-Zadeh, 2015). An increased amount of potassium can 
lead to hyperkalemia, which can increase the risk of sudden cardiac death (Huang, 2015). 
Education is needed for these patients because foods high in potassium can also contribute to 
heart health. Professionals are required to provide the most beneficial options for patients to eat 
without over consuming and overloading the body with potassium (Kalantar-Zadeh, 2015). The 
National Kidney Foundation recommends potassium be limited to 2000 milligrams per day for 
dialysis patients (National Kidney Foundation, 2017).  
 
Malnutrition Risk for a Patient on Dialysis 
 Screenings for malnutrition are essential to make sure patients are not at nutritional risk. 
As noted earlier, there are a larger number of nutrients to be assessed, and this is key to help with 
the survival rate when patients are in the hospital. Some causes of malnutrition include anorexia, 
reduced energy intake due to diet change, increased rate of protein catabolism and nutrient loss 
in dialysis (Naini, 2016).  
 The prevalence of anorexia in the CKD population is around 56% (Schick, 2018). 
Anorexia in dialysis patients relates to appetite inhibitors, pro-inflammatory cytokines and 
neurotransmitter inhibitors related to satiety (Chazot, 2009). Because of the abdominal 
discomfort a patient can experience, anorexia is common in hemodialysis, but there is limited 
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research on the direct relationship (Bergstroem, 1996). Anorexia can also increase a malnutrition 
inflammation score (MIS), which can decrease quality  
of life because of low nutrient intake (Naini, 2016). 
 Nutrient loss is a topic of interest in dialysis specifically with protein. PEW is the 
byproduct of low nutrient intake and is common in those who are undernourished, as in dialysis 
(Koefoed, 2016). Muscle or protein wasting can occur during dialysis because of inflammation, 
hormone imbalances and a decreased dietary intake (Ikizler, 2010). Monitoring of protein 
wasting will be critical to assess the patient and a variety of screening tools may be needed on a 
weekly or monthly basis (Radjen, 2018).  
There are a variety of tools practitioners can use to test nutritional status, and one is the 
nutritional risk index (NRI). The NRI is used as a screening tool by looking at different measures 
such as albumin, creatine and nitrogen. Knowing these levels will allow practitioners and 
dietitians to evaluate the status of dialysis patients and avoid malnutrition (Prasad, 2016). 
 
Nutrients to Aid in Dialysis Patients 
 Even though there is a restriction on what dialysis patients can eat, there are nutrients that 
are needed to help with their treatment. Different vitamins and minerals have anti-inflammatory 
properties that can help manage the symptoms of CKD. Vitamin B12, folate, probiotics and trace 
minerals are some of the common nutrients that are seen to help dialysis patients.  
Vitamin B12 aids in brain and nervous system function and can also help with hemoglobin 
and DNA production (Shaban, 2014). Animal sources as well as dairy products contain a high 
amount of vitamin B12. The amount of vitamin B12 is typically normal in dialysis patients; 
however, patients need to keep an eye on it in fear of malnutrition (Shaban, 2014). Vitamin B12 is 
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also essential for folate metabolism for absorption, which makes looking at the concentration of 
both essential for metabolism and nutritional normalization (Chazot, 2016).  
Folate is another nutrient of interest because of its importance in red blood cell 
production. One treatment for patients on dialysis is iron replacement therapy to help bring red 
blood cells to a normal level and can also eliminate the amount of homocysteine in CKD 
patients. Homocysteine is an amino acid that is formed when protein is broken down and can 
cause blood clots and heart attacks. Folate is a nutrient that can be used for these patients to help 
reduce the amount of homocysteine so long as there is adequate vitamin B12 stores (Schaefer, 
2002; Shaban, 2014). Folate can be found in a variety of animal products and vegetables, but 
looking at medications will help make sure there is no interference with folate metabolism 
(Chazot, 2016). 
Trace minerals are needed for the body and some of them include iron, zinc and copper. 
Iron will help with the red blood cells, copper works in conjunction with iron for blood cell 
production and zinc aids in wound healing. One of the things that needs to be monitored is the 
amount of these trace minerals to avoid toxicity. Copper is an element that, if ingested too much, 
can lead to toxicity, so it needs to be monitored (Shaban, 2014; Mafra 2016). 
Probiotics contain different bacteria strains that are considered “good bacteria.” It helps 
the digestive system in enhancing the health of the gut. Dialysis patients’ gut can be affected 
because of the amount of toxins in the body as well as restrictions on certain food items. 
Probiotics can also help with one of the risks of dialysis, which is inflammation (Bassola, 2016). 
One research study in particular looked at the correlation probiotics and inflammation and it 
concluded that an increase in probiotics led to a lower pro-inflammatory cytokines and a 
reduction in proteinuric kidney disease (Khodor, 2017). Fiber can help normalize the gut, but 
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since dialysis patients are on a low fruit and vegetable diet, there needs to be something else to 
help with the inflammation and composition of the gut microbiota (Bassola, 2016). 
 
Importance of Fiber 
 Dietary fiber is found in fruits, vegetables, whole grains, beans and legumes and other 
enriched sources. Fiber is classified in two ways: soluble and insoluble fiber. Each classification 
aids in rate of digestion in different ways and moves either quicker or slower in the stomach and 
small intestine (Ötles, 2014). Dietary fiber completes its full digestion in the large intestine (Li, 
2017). An increase in fiber can help with a better diet quality and has helped with different 
chronic diseases. 
 Fiber has been shown to help lower cholesterol, improve glucose tolerance and help with 
general heart health (Lockyer, 2016). Fiber has been shown to help lower cholesterol and have 
an inverse correlation with risk factors associated with coronary disease (Naumann, n.d.). Bile 
salts are created from the liver in response to cholesterol metabolism (Wang, n.d.). Fiber 
prevents the bile salts from reabsorbing which encourages the liver to produce more bile salts 
and reduce the amount of cholesterol (Naumann, n.d.). Fiber is also beneficial for overall heart 
health which can lead to a reduction in mortality in individuals. In a meta analysis of research 
looking at the correlation of fiber and heart health, studies concluded that because of the lipid 
lowering properties in fiber, it significantly reduces the risk of mortality from cardiovascular 
disease (McRae, 2017). Since patients who have CKD are also at risk for cardiovascular disease, 
previous research has looked directly into the effects lowering cardiovascular disease risks in 
these patients.  
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As mentioned in the previous section, fruits and vegetables are typically reduced in CKD 
patients on dialysis. Fiber is a key component to help create short chain fatty acids to be moved 
into the walls of the colon. This is going to help promote normalization in the gut and a healthy 
gut microbiota. Fiber has also been shown to help reduce the amount of inflammation in the 
body (Bassola, 2016). Previous research has observed fiber consumption and its relation to 
inflammatory diseases such as colitis, diabetes and cancer. Reserach confirmed that individuals 
who consumed more dietary fiber had a lower incidence of these diseases (Maslowski, 2011). 
Previous research has also looked at fiber intake and its effect on kidney health. Dietary 
fiber has been shown to have a positive correlation on kidney health by an increase in nitrogen 
excretion and a reduction in blood urea nitrogen (BUN) (Xu, 2014). A higher BUN level is 
associated with a higher cardiovascular disease mortality risk, and a lower BUN level has been 
seen to aid in the clinical side by decreasing hospitalizations and improving clinical outcomes 
(JuJo, 2017). 
 Since fiber has numerous benefits, it makes researchers wonder if it can help with the 
treatment of dialysis patients. Since dialysis patients are restricted in common high fiber foods, it 
begs the question on the connection of fiber and these patients. In previous studies, the 
correlation of fiber and GFR were observed see if the amount of fiber impacted the total GFR. 
One study in particular concluded that the increase in fiber intake resulted in the retard of the 
decrease of GFR and other pro-inflammatory factors (Lu Lu, 2017). Another study observed 
dietary fiber and its effects on the colon. The study determined that fiber can reduce plasma urea 
levels by 10-20% (Sirich, 2015). There are limited studies done on dialysis patients and, if there 
is a connection, it could lead to another treatment to help inflammation.     
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Quality of Life and Symptoms 
 There has been a connection with patients in ESRD and poor quality of life and even an 
increase in mortality (Gupta, 2016). Quality of life can even be identified in terms of 
malnutrition, poor nutritional status, physical and emotional feelings. The mildest form of 
malnutrition or undernutrion can lead to a decrease in quality of life for these individuals 
(Moreira, 2013). There are multiple symptoms that can occur during or after dialysis, and it is 
dependent on the person.  
Nausea and vomiting are among some of the many symptoms of dialysis. There are a 
variety of reasons an individual can experience nausea or vomiting such as gastrointestinal 
distress, drop in blood pressure, anxiety, water imbalances and the amount of urea in the body 
(Asgari, 2017). The renal diet is a restrictive diet intended to help during the treatment. Patients 
who have CKD have increased levels of sodium and potassium in their saliva, which changes the 
taste of certain foods and can cause nausea as well (Manley, 2015). Some ways to help patients 
with nausea are to talk to a professional about what the appropriate time to eat is, whether it is 
before or after treatment and evaluating electrolyte imbalances (Borzou, 2016).  
Depression has been shown to affect 20-30% of people on hemodialysis (Treadwell, 
2017). Depression can correlate with an increased level of pro-inflammatory cytokines in an 
already highly inflammatory disease (Knuth, 2014). Previous studies have looked at the quality 
of life of patients on dialysis, and it is lower than the general population leading to the 
consideration of depression treatment alongside hemodialysis (Miljanović, 2018). Depression 
can affect the treatment because the patient might not be motivated to go to treatment. 
(Treadwell, 2017).  
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Fatigue does not affect each patient in the same way. Roughly 70-97% of patients who 
are diagnosed with CKD experience fatigue (Joshwa , 2017). Some describe it as weakness, 
tired, emotional or exhausted (Bossola, 2011). Roughly 45-80% of patients also experience 
fatigue while on dialysis, and this has been shown to also increase mortality and decrease quality 
of life (Moledina, 2015). This fatigue can also be from sleep disorders of the patient. Sleep 
disorders are more prevalent in individuals on dialysis in comparison to those who are not on 
dialysis (Moledina, 2015). This can be rationalized by the fluid buildup, toxins being flushed out 
of the body and over catabolic state of the treatment (Chu, 2018).  
Different gastrointestinal (GI) disorders such as gastro-esophageal reflux or esophagitis 
can affect patients, and this can in turn lead to malnutrition in a patient (Esfahani, 2009). The 
duration of the hemodialysis treatment in terms of months can also impact GI distress. One study 
in particular concluded that 70% of patients experience some sort of GI issues yet the longer a 
patient is on dialysis the less symptoms they experience (Vui Heng Chong, 2010). All of the 
symptoms patients report are causal of dialysis can affect the quality of life as well as eating 
patterns. 
 
Summary 
CKD is a progressive disease and, upon complete failure of the kidneys, requires dialysis 
to help the patient maintain health status and provide a substitute for normal kidney function. 
There are two different styles of dialysis, and the decision on which treatment option to use is 
dependent on the patient and the current function of the kidneys. Malnutrition is risk associated 
with dialysis because of the symptoms associated with dialysis such as fatigue, nausea and 
vomiting. Nutrition therapy is a cost effective and non-invasive intervention that can improve 
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patient outcomes and quality of life.  Previous research has looked into a variety of vitamins and 
minerals such as B12, folate, probiotics and trace minerals to determine if there is a connection to 
those nutrients and the relation to maintenance of health and wellness of the patient. Fiber is a 
topic that has limited research on for dialysis patients. There are many benefits to fiber 
consumption in the general population such as decreased inflammation, heart health benefits and 
controlling blood glucose. There is limited research with fiber and its relation to CKD patients 
directly. In dialysis patients, fiber plays key roles in decreasing inflammation, decreased GFR 
and plasma urea. The overall goal of nutrition in CKD patients on dialysis is to maintain the 
quality of life of the patient during the progression of the disease.  
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